Are ancillary studies of any utility in risk assessment of Barrett’s esophagus and dysplasia? episode artwork

EPISODE · Aug 18, 2022 · 21 MIN

Are ancillary studies of any utility in risk assessment of Barrett’s esophagus and dysplasia?

from Springer Nature · host Springer Nature

Modern Pathology have recently launched a new series of reviews addressing controversial issues in pathology. In this episode of ModPath CHAT, Dr. Elizabeth Montgomery, a world renowned expert in gastrointestinal pathology gives her point of view on the utility of ancillary testing for risk stratification of Barrett’s esophagus and dysplasia.

Episode metadata supplied by the publisher feed · Published Aug 18, 2022

Embed this episode

NOW PLAYING

Are ancillary studies of any utility in risk assessment of Barrett’s esophagus and dysplasia?

0:00 21:31

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Springer Nature?

This episode is 21 minutes long.

When was this Springer Nature episode published?

This episode was published on August 18, 2022.

Can I download this Springer Nature episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!